Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 235

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis

Open access
Kumar, Avinash, Davuluri, Gangarao, Silva, Rafaella Nascimento e, Engelen, Marielle P.K.J., Ten Have, Gabrie A.M., Prayson, Richard, Deutz, Nicolaas E.P., Dasarathy, Srinivasan · 2017 · Hepatology

Abstract

Sarcopenia or skeletal muscle loss is a frequent, potentially reversible complication in cirrhosis that adversely affects clinical outcomes. Hyperammonemia is a consistent abnormality in cirrhosis that results in impaired skeletal muscle protein synthesis and breakdown (proteostasis). Despite the availability of effective ammonia‐lowering therapies, whether lowering ammonia restores proteostasis and increases muscle mass is unknown. Myotube diameter, protein synthesis, and molecular responses in C2C12 murine myotubes to withdrawal of ammonium acetate following 24‐hour exposure to 10 mM ammonium acetate were complemented by in vivo studies in the hyperammonemic portacaval anastomosis rat and sham‐operated, pair‐fed Sprague‐Dawley rats treated with ammonia‐lowering therapy by l‐ornithine l‐aspartate and rifaximin orally for 4 weeks. We observed reduced myotube diameter, impaired protein synthesis, and increased autophagy flux in response to hyperammonemia, which were partially reversed following 24‐hour and 48‐hour withdrawal of ammonium acetate. Consistently, 4 weeks of ammonia‐lowering therapy resulted in significant lowering of blood and skeletal muscle ammonia, increase in lean body mass, improved grip strength, higher skeletal muscle mass and diameter, and an increase in type 2 fibers in treated compared to untreated portacaval anastomosis rats. The increased skeletal muscle myostatin expression, reduced mammalian target of rapamycin complex 1 function, and hyperammonemic stress response including autophagy markers normally found in portacaval anastomosis rats were reversed by treatment with ammonia‐lowering therapy. Despite significant improvement, molecular and functional readouts were not completely reversed by ammonia‐lowering measures.Conclusion: Ammonia‐lowering therapy results in improvement in skeletal muscle phenotype and function and molecular perturbations of hyperammonemia; these preclinical studies complement previous studies on ammonia‐induced skeletal muscle loss and lay the foundation for prolonged ammonia‐lowering therapy to reverse sarcopenia of cirrhosis. (H epatology 2017;65:2045‐2058).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.29107

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 235

Metadata

Authors
Kumar, A., Davuluri, G., Silva, R. N. E., Engelen, M. P. K. J., Ten Have, G. A. M., Prayson, R., Deutz, N. E. P., & Dasarathy, S.
Venue
Hepatology
Published
2017-04-28
Volume
65
Issue
6
Pages
2045-2058
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W2588938745
Cited by
235
References
1
FWCI
11.85
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis. https://app.cochat.ai/papers/10.1002/hep.29107
The paper
Kumar, A., Davuluri, G., Silva, R. N. E., Engelen, M. P. K. J., Ten Have, G. A. M., Prayson, R., Deutz, N. E. P., & Dasarathy, S. (2017). Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis. Hepatology. https://doi.org/10.1002/hep.29107

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.